Statistics for Development and characterization of a novel model of ibrutinib resistance in Chronic Lymphocytic Leukemia (CLL) that displays sensitivity to PI3K inhibition
Total visits
views | |
---|---|
Development and characterization of a novel model of ibrutinib resistance in Chronic Lymphocytic Leukemia (CLL) that displays sensitivity to PI3K inhibition | 192 |
Total visits per month
views | |
---|---|
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 1 |
April 2025 | 0 |
May 2025 | 0 |
File Visits
views | |
---|---|
Ehiremen_Godsent.pdf | 176 |
GEhiremen_masters_thesis_practicum_final_report.pdf | 1 |
Top country views
views | |
---|---|
United States | 47 |
Canada | 34 |
China | 26 |
Ireland | 17 |
Hong Kong SAR China | 13 |
Germany | 12 |
India | 9 |
Italy | 6 |
United Kingdom | 3 |
Japan | 3 |
Finland | 2 |
South Korea | 2 |
Saudi Arabia | 2 |
Sweden | 2 |
Singapore | 2 |
Taiwan | 2 |
Vietnam | 2 |
Cyprus | 1 |
Spain | 1 |
Iran | 1 |
Nigeria | 1 |
Netherlands | 1 |
Poland | 1 |
Top city views
views | |
---|---|
Winnipeg | 31 |
Beijing | 18 |
Ashburn | 17 |
Dublin | 10 |
Babail | 3 |
Miami | 3 |
Padova | 3 |
Tokyo | 3 |
Zhengzhou | 3 |
Bengaluru | 2 |
Clifton | 2 |
Hanoi | 2 |
Helsinki | 2 |
Hyderabad | 2 |
Inglewood | 2 |
Barcelona | 1 |
Brooklyn | 1 |
Busanjin-gu | 1 |
Calgary | 1 |
Central | 1 |
Chieti | 1 |
City of Saint Peters | 1 |
Des Moines | 1 |
El Cajon | 1 |
Fairless Hills | 1 |
Gulou | 1 |
Karlstad | 1 |
Katowice | 1 |
Kernersville | 1 |
Lagos | 1 |
Las Vegas | 1 |
Leicester | 1 |
Lincoln | 1 |
Los Angeles | 1 |
Lund | 1 |
Mogliano Veneto | 1 |
Mumbai | 1 |
Nagold | 1 |
New York | 1 |
Nijmegen | 1 |
Oklahoma City | 1 |
Pescara | 1 |
Richmond | 1 |
Seattle | 1 |
Shanghai | 1 |
Shenzhen | 1 |
Silver Spring | 1 |
Singapore | 1 |
Stanford | 1 |
Surat | 1 |
Yongsan-gu | 1 |
Zhangzhou | 1 |